Opioids: shortage status in Canada
8 of the 16 opioids rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Butalbital Acetylsalicylic Acid Codeine Caffeine (Fiorinal-C) Widespread shortage 2 of 4 reported products affected
Methocarbamol Codeine Acetylsalicylic Acid (Methoxisal-C) Widespread shortage 4 of 5 reported products affected
Acetaminophen Oxycodone (Rivacocet) Partial shortage 2 of 9 reported products affected · est. return Aug 20, 2026
Caffeine Acetaminophen Codeine (Tylenol) Partial shortage 2 of 11 reported products affected
Hydromorphone (Dilaudid) Partial shortage 7 of 51 reported products affected · est. return Oct 9, 2026
Morphine (Statex) Partial shortage 4 of 53 reported products affected
Oxycodone (Oxyneo) Partial shortage 2 of 35 reported products affected · est. return Jul 31, 2026
Tramadol Acetaminophen (Tramacet) Partial shortage 1 of 14 reported products affected
Acetaminophen Codeine Caffeine (Atasol) Discontinued 0 of 2 reported products affected
Acetylsalicylic Acid Codeine Caffeine (Ac&c) Discontinued 0 of 2 reported products affected
Acetylsalicylic Acid Oxycodone No current shortage
Codeine Acetaminophen (Tylenol) No current shortage
Methocarbamol Acetaminophen Codeine (Spasmhalt-8) No current shortage
Pentazocine (Talwin) Discontinued 0 of 2 reported products affected
Tapentadol (Nucynta Extended-Release) No current shortage
Tramadol (Zytram Xl) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.